These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30984535)

  • 1. The hydrophobic C-terminal sequence of transthyretin affects its catalytic kinetics towards amidated neuropeptide Y.
    Tangthavewattana S; Leelawatwattana L; Prapunpoj P
    FEBS Open Bio; 2019 Apr; 9(4):594-604. PubMed ID: 30984535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificity of transthyretin: identification of natural substrates in the nervous system.
    Liz MA; Fleming CE; Nunes AF; Almeida MR; Mar FM; Choe Y; Craik CS; Powers JC; Bogyo M; Sousa MM
    Biochem J; 2009 Apr; 419(2):467-74. PubMed ID: 19138167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The catalytic kinetics of chicken transthyretin towards human Aβ
    Tola AJ; Leelawatwattana L; Prapunpoj P
    Comp Biochem Physiol C Toxicol Pharmacol; 2019 Dec; 226():108610. PubMed ID: 31454704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the N-terminal sequence on the binding affinity of transthyretin for human retinol-binding protein.
    Leelawatwattana L; Praphanphoj V; Prapunpoj P
    FEBS J; 2011 Sep; 278(18):3337-47. PubMed ID: 21777382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y expression and function during osteoblast differentiation--insights from transthyretin knockout mice.
    Nunes AF; Liz MA; Franquinho F; Teixeira L; Sousa V; Chenu C; Lamghari M; Sousa MM
    FEBS J; 2010 Jan; 277(1):263-75. PubMed ID: 19954489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transthyretin knockouts are a new mouse model for increased neuropeptide Y.
    Nunes AF; Saraiva MJ; Sousa MM
    FASEB J; 2006 Jan; 20(1):166-8. PubMed ID: 16263939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in structure of the N-terminal region of transthyretin produces change in affinity of transthyretin to T4 and T3.
    Prapunpoj P; Leelawatwatana L; Schreiber G; Richardson SJ
    FEBS J; 2006 Sep; 273(17):4013-23. PubMed ID: 16879610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transthyretin, a new cryptic protease.
    Liz MA; Faro CJ; Saraiva MJ; Sousa MM
    J Biol Chem; 2004 May; 279(20):21431-8. PubMed ID: 15033978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transthyretin is a metallopeptidase with an inducible active site.
    Liz MA; Leite SC; Juliano L; Saraiva MJ; Damas AM; Bur D; Sousa MM
    Biochem J; 2012 May; 443(3):769-78. PubMed ID: 22332999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing the length and hydrophobicity of the C-terminal sequence of transthyretin strengthens its binding affinity to retinol binding protein.
    Poodproh R; Kaewmeechai S; Leelawatwattana L; Prapunpoj P
    FEBS Open Bio; 2017 Dec; 7(12):1891-1898. PubMed ID: 29226076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis.
    Mangione PP; Porcari R; Gillmore JD; Pucci P; Monti M; Porcari M; Giorgetti S; Marchese L; Raimondi S; Serpell LC; Chen W; Relini A; Marcoux J; Clatworthy IR; Taylor GW; Tennent GA; Robinson CV; Hawkins PN; Stoppini M; Wood SP; Pepys MB; Bellotti V
    Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1539-44. PubMed ID: 24474780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the CD Loop by Enzymatic Cleavage Promotes the Formation of Toxic Transthyretin Oligomers through a Common Transthyretin Misfolding Pathway.
    Dasari AKR; Arreola J; Michael B; Griffin RG; Kelly JW; Lim KH
    Biochemistry; 2020 Jun; 59(25):2319-2327. PubMed ID: 32500705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the brown hagfish Paramyxine atami transthyretin: Metal ion-dependent thyroid hormone binding.
    Suzuki S; Kasai K; Nishiyama N; Ishihara A; Yamauchi K
    Gen Comp Endocrinol; 2017 Aug; 249():1-14. PubMed ID: 28242306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central transthyretin acts to decrease food intake and body weight.
    Zheng F; Kim YJ; Moran TH; Li H; Bi S
    Sci Rep; 2016 Apr; 6():24238. PubMed ID: 27053000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism.
    Si JB; Kim B; Kim JH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometric immunoassay for quantitative determination of transthyretin and its variants.
    Trenchevska O; Kamcheva E; Nedelkov D
    Proteomics; 2011 Sep; 11(18):3633-41. PubMed ID: 21751365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of amyloidogenic segments of human transthyretin.
    Saelices L; Sievers SA; Sawaya MR; Eisenberg DS
    Protein Sci; 2018 Jul; 27(7):1295-1303. PubMed ID: 29626847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium Binds to Transthyretin with Low Affinity.
    Cantarutti C; Mimmi MC; Verona G; Mandaliti W; Taylor GW; Mangione PP; Giorgetti S; Bellotti V; Corazza A
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic optimization and structural evaluation of quinoline derivatives as transthyretin amyloidogenesis inhibitors.
    Kim B; Park H; Lee SK; Park SJ; Koo TS; Kang NS; Hong KB; Choi S
    Eur J Med Chem; 2016 Nov; 123():777-787. PubMed ID: 27541261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A molecular mechanism for transthyretin amyloidogenesis.
    Yee AW; Aldeghi M; Blakeley MP; Ostermann A; Mas PJ; Moulin M; de Sanctis D; Bowler MW; Mueller-Dieckmann C; Mitchell EP; Haertlein M; de Groot BL; Boeri Erba E; Forsyth VT
    Nat Commun; 2019 Feb; 10(1):925. PubMed ID: 30804345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.